Latest News for: cd3

Edit

Exhibits Submission for Asset-Backed Securities Offerings (Form ABS-EE) (CD 2017-CD3 Mortgage Trust)

Public Technologies 25 Nov 2025
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington D.C. 20549 ... 333-207132-10 ... CD 2017-CD3 Mortgage Trust ... CD 2017-CD3 Mortgage Trust published this content on November 25, 2025, and is solely responsible for the information contained herein.
Edit

Asset-Backed Issuer Distribution Report (Form 10-D) (CD 2017-CD3 Mortgage Trust)

Public Technologies 25 Nov 2025
). Distribution Date.. 11/13/25. CD 2017-CD3 Mortgage Trust. Determination Date.. 11/06/25 ... 12/12/25 ... Series 2017-CD3 ... 2 ... 3 ... CD 2017-CD3 Mortgage Trust published this content on November 25, 2025, and is solely responsible for the information contained herein.
Edit

Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T ...

Nasdaq Globe Newswire 13 Nov 2025
(“Third Arc Bio”), today announced a licensing agreement under which Third Arc Bio will utilize Adagene’s SAFEbody technology platform to generate masked CD3 T cell engagers ...
Edit

Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager (Form 8-K) (Abpro Holdings Inc)

Public Technologies 04 Nov 2025
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager ● CT-P72/ABP-102 poster selected as one of the Top 150 abstracts out of more than 1,300 submissions at SITC 2025.
Edit

Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025

Nasdaq Globe Newswire 03 Nov 2025
MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ...
Edit

Xencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in ...

Business Wire 25 Oct 2025
(NASDAQ.XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the ...
Edit

Material Event (Form 8-K) (CD 2017-CD3 Mortgage Trust)

Public Technologies 30 Sep 2025
). Item 8.01 Other Events ... Attachments Original document Permalink. Disclaimer. CD 2017-CD3 Mortgage Trust published this content on September 30, 2025, and is solely responsible for the information contained herein ... (noodl. 126771445) .
  • 1
×